Clinical Trials Browser

Phase 2 × INDUSTRY × afuresertib × Clear all

NCT04374630 2025-09-10

PROFECTA-II

Phase 2 Completed

Platinum-resistant Ovarian Cancer

NCT01531894 2019-07-09

Continuation Study of the Oral AKT Inhibitor GSK2110183

Phase 2 Completed

11 enrolled 8 charts

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms